BRIEF-Health Canada Permits COVID-19 Patients With Respiratory Failure To Be Given Nuvox Pharma’s Oxygen Restorative In Stage Iia Medical Trial

June 29 (Reuters) – Nuvox Pharma:

HEALTH CANADA PERMITS COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO BE GIVEN NUVOX PHARMA’S OXYGEN THERAPEUTIC IN STAGE IIA CLINICAL TRIAL

NUVOX PHARMA – RECEIVED “NO OBJECTION LETTER” FROM HEALTH CANADA TO PROCEED WITH STAGE IIA MEDICAL TRIAL OF NANO2 IN COVID-19 TOPICS WITH AHRF Source text for Eikon:]